الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 136 |  |  |
| | | from | 136 | | |
Abstract
People with type 1 diabetes mellitus (T1DM) and pregnant women need special attention. Individualisation of treatment options is the proper approach for the management of diabetes during Ramadan. This process can be broken down into a number of steps involving pre-Ramadan patient assessment, medication adjustment during Ramadan and post-Ramadan follow-up (Al-Arouj et al., 2010).
The decision by an individual with T1DM to fast during Ramadan must be respected. There is some evidence to suggest that, as long as they are otherwise stable and healthy, they can do so safely. However, strict medical supervision and focused education on how to control their glycemic levels is essential (IDF, 2016).
This study aimed to demonstrate the impact of fasting on primarily on ẻGFR & microalbuminuria in people with type 1 diabetes and secondarily on neuropathy & retinopathy. It was conducted on 60 patients with T1DM. All patients underwent full history taking, full clinical examination and biochemical tests including FBG, 2h PPBG, HbA1c, fructosamine, s.creatinine, BUN, uACR, eGFR, fundus examination and DN4 Q.
There had been significant difference between pre and post-fasting as regards weigһt and BMI, and non significant difference regards waist circumference.
Also highly significant difference between basal and bolus doses before and during Ramadan.
There had been no significant difference between pre and post Ramadan regarding fundus examination and a significant difference regarding DN4 Q.
Regarding no. of successful fasting days and attacks of hypoglycemia, a significant difference was found.
Also regarding laboratory results, there had been significant difference in FBS, 2hr PPBG, BUN, s.creatinine, uACR, eGFR, and fructosamine.